168 related articles for article (PubMed ID: 31728810)
1. SATB2 and NGR1: potential upstream regulatory factors in uterine leiomyomas.
Sato S; Maekawa R; Tamura I; Shirafuta Y; Shinagawa M; Asada H; Taketani T; Tamura H; Sugino N
J Assist Reprod Genet; 2019 Nov; 36(11):2385-2397. PubMed ID: 31728810
[TBL] [Abstract][Full Text] [Related]
2. Potential mechanisms of aberrant DNA hypomethylation on the x chromosome in uterine leiomyomas.
Sato S; Maekawa R; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Sugino N
J Reprod Dev; 2014 Mar; 60(1):47-54. PubMed ID: 24291816
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.
Sampath D; Zhu Y; Winneker RC; Zhang Z
J Clin Endocrinol Metab; 2001 Apr; 86(4):1707-15. PubMed ID: 11297607
[TBL] [Abstract][Full Text] [Related]
4. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.
Mangrulkar RS; Ono M; Ishikawa M; Takashima S; Klagsbrun M; Nowak RA
Biol Reprod; 1995 Sep; 53(3):636-46. PubMed ID: 7578688
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas.
Maekawa R; Sato S; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Takaki E; Nakai A; Sugino N
PLoS One; 2013; 8(6):e66632. PubMed ID: 23818951
[TBL] [Abstract][Full Text] [Related]
7. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium.
Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J
Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091
[TBL] [Abstract][Full Text] [Related]
8. H3K4me3 mediates uterine leiomyoma pathogenesis via neuronal processes, synapsis components, proliferation, and Wnt/β-catenin and TGF-β pathways.
Carbajo-García MC; Juarez-Barber E; Segura-Benítez M; Faus A; Trelis A; Monleón J; Carmona-Antoñanzas G; Pellicer A; Flanagan JM; Ferrero H
Reprod Biol Endocrinol; 2023 Jan; 21(1):9. PubMed ID: 36703136
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the Wnt5b gene in leiomyoma cells: implications for a role of the Wnt signaling pathway in the uterine benign tumor.
Mangioni S; Viganò P; Lattuada D; Abbiati A; Vignali M; Di Blasio AM
J Clin Endocrinol Metab; 2005 Sep; 90(9):5349-55. PubMed ID: 15972578
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/β-catenin pathway.
Corachán A; Ferrero H; Aguilar A; Garcia N; Monleon J; Faus A; Cervelló I; Pellicer A
Fertil Steril; 2019 Feb; 111(2):397-407. PubMed ID: 30458994
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma.
Navarro A; Yin P; Monsivais D; Lin SM; Du P; Wei JJ; Bulun SE
PLoS One; 2012; 7(3):e33284. PubMed ID: 22428009
[TBL] [Abstract][Full Text] [Related]
12. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
13. 5-aza-2'-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt/β-catenin pathway in human uterine leiomyomas.
Carbajo-García MC; Corachán A; Segura-Benitez M; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
Reprod Biol Endocrinol; 2021 Jul; 19(1):106. PubMed ID: 34233687
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth.
Wolańska M; Bańkowski E
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):238-44. PubMed ID: 16564125
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells.
Wang Y; Feng G; Wang J; Zhou Y; Liu Y; Shi Y; Zhu Y; Lin W; Xu Y; Li Z
Hum Reprod; 2015 Jan; 30(1):61-70. PubMed ID: 25398968
[TBL] [Abstract][Full Text] [Related]
16. Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma.
Maekawa R; Yagi S; Ohgane J; Yamagata Y; Asada H; Tamura I; Sugino N; Shiota K
J Reprod Dev; 2011 Oct; 57(5):604-12. PubMed ID: 21685710
[TBL] [Abstract][Full Text] [Related]
17. Targeting leiomyomas with all-trans-retinoic acid at phosphoinositide 3-kinase pathway suppression: Effective roles of β-catenin and of signaling interactions.
Friedman N; Shushan A; Rojansky N; Shveiky D; Levitzki R; Chaouat M; Ben-Bassat H
J Obstet Gynaecol Res; 2016 Oct; 42(10):1343-1353. PubMed ID: 27354299
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of gene expression pattern in has-miR-197 over-expressed human uterine leiomyoma cells.
Ling J; Wu X; Fu Z; Tan J; Xu Q
Biomed Pharmacother; 2015 Oct; 75():226-33. PubMed ID: 26311392
[TBL] [Abstract][Full Text] [Related]
19. [Expression of bcl-2 protein in uterine leiomyomas and normal myometrium].
Zhang ZL; Zhang Y; Xu BQ
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):363-5. PubMed ID: 12536738
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth.
Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E
Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
